Stay updated with breaking news from Patrickj Haley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Exelixis (NASDAQ:EXEL – Get Free Report)‘s stock had its “outperform” rating restated by William Blair in a report released on Monday, RTT News reports. Several other equities research analysts have also recently commented on the company. Royal Bank of Canada reissued an “outperform” rating and issued a $26.00 price target on shares of Exelixis in […]
Exelixis, Inc. (NASDAQ:EXEL – Get Free Report)’s stock price reached a new 52-week high during trading on Tuesday . The company traded as high as $23.84 and last traded at $23.72, with a volume of 124977 shares. The stock had previously closed at $23.34. Analysts Set New Price Targets A number of equities research analysts […]
Royal Bank of Canada restated their outperform rating on shares of Exelixis (NASDAQ:EXEL – Free Report) in a research note released on Wednesday morning, Benzinga reports. The firm currently has a $26.00 price objective on the biotechnology company’s stock. A number of other brokerages have also recently commented on EXEL. Stifel Nicolaus restated a hold […]
Equities research analysts at Citigroup assumed coverage on shares of Exelixis (NASDAQ:EXEL – Get Free Report) in a note issued to investors on Friday, Briefing.com reports. The brokerage set a “buy” rating and a $31.00 price target on the biotechnology company’s stock. Citigroup’s price target suggests a potential upside of 32.99% from the company’s previous […]
LSV Asset Management lowered its stake in shares of Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 39.8% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,267,475 shares of the biotechnology company’s stock after selling 838,909 shares during the quarter. LSV Asset Management owned […]